Investors Research Corp’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-12,700
Closed -$344K 1046
2020
Q4
$344K Hold
12,700
0.14% 226
2020
Q3
$319K Sell
12,700
-26,925
-68% -$393K 0.15% 195
2020
Q2
$302K Sell
39,625
-350
-0.9% -$2.56K 0.15% 207
2020
Q1
$366K Buy
39,975
+325
+0.8% +$1.96K 0.23% 163
2019
Q4
$205K Sell
39,650
-775
-2% -$4.98K 0.09% 277
2019
Q3
$235K Sell
40,425
-575
-1% -$2.58K 0.12% 235
2019
Q2
$131K Sell
41,000
-175
-0.4% -$597 0.07% 328
2019
Q1
$169K Sell
41,175
-575
-1% -$3.64K 0.09% 289
2018
Q4
$264K Sell
41,750
-250
-0.6% -$2.6K 0.18% 199
2018
Q3
$694K Sell
42,000
-675
-2% -$11.5K 0.4% 90
2018
Q2
$713K Buy
+42,675
New +$691K 0.41% 84

Other funds holding ACH

Investors Research Corp's ACH Position: Q1 2021 in Review

Investors Research Corp sold out of Accendra Health (ACH) in Q1 2021, closing a stake of 12,700 shares — an estimated $344K sold.

Investors Research Corp first reported a position in ACH in Q2 2018 and held it in 11 quarters. The position peaked at $713K in Q2 2018. 253 funds tracked by Wall St. Rank hold ACH as of Q1 2021.

  • Investors Research Corp reported no remaining Accendra Health position as of Q1 2021 after selling out during the quarter.
  • Investors Research Corp sold 12,700 Accendra Health shares in Q1 2021, an estimated $344K.
  • Investors Research Corp first reported a position in Accendra Health in Q2 2018 and held it in 11 quarters.
  • Investors Research Corp's Accendra Health position peaked at $713K in Q2 2018.
  • 253 funds tracked by Wall St. Rank held Accendra Health as of Q1 2021.

Based on Investors Research Corp's 13F filing for Q1 2021, filed 28 Apr 2021.